トリメリチスアンヒドリドによる肺出血および血液溶解性貧血
Lancet (London, England)
|August 18, 1979
まとめ
エポキシ樹脂粉のトリメリチクアンヒドリド (TMA) に曝露すると,深刻な健康問題が発生する可能性があります. ヘモリチス貧血とヘモプティゼを発症した労働者は,TMA暴露を避ける後に回復し,免疫反応を示唆しました.
科学分野:
- 職業衛生は,健康に関するものです.
- 毒理学 毒理学 毒理学
- 免疫学 免疫学とは
背景:
- トリメリチウムアンヒドリド (TMA) は,エポキシ樹脂に使用される化学物質です.
- TMAは,喘息などの呼吸器疾患を引き起こすことが知られている.
- TMA曝露の肺外効果はあまり理解されていない.
研究 の 目的:
- 職業上のトリメリチスアンヒドリド (TMA) 曝露による肺外毒性の影響を調査する.
- TMA誘発の血液溶解性貧血と血栓解離の背後にある潜在的なメカニズムを特定する.
主な方法:
- TMAを含むエポキシ樹脂粉に曝された2人の男性労働者のケーススタディ.
- 症状,貧血,および暴露後の回復停止の臨床観察.
- 報告された7つの同様の症例のレビュー.
- TMAハプテニゼートされたタンパク質と細胞を用いた免疫学的研究が,患者の血清に実施された.
主要な成果:
- 2人の労働者は,TMAの曝露後に,血解性貧血と血解離症を発症した.
- 症状と貧血は,被曝から取り除かれた後,自発的に解消しました.
- 7つの同様の症例は,肺外毒性のパターンを示唆しています.
- 免疫学的研究は,潜在的な免疫メカニズムが関与していることを示しました.
結論:
- トリメリチス無水化物 (TMA) の職業的曝露は,血液溶解性貧血および血液解離を含む肺外毒的効果を引き起こす可能性があります.
- これらの効果は,免疫学的メカニズムによって媒介されるようです.
- TMAの毒性を完全に理解するためにさらなる研究が必要である.
さらに関連する動画
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
関連する概念動画
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
